跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,758 条关于
“BMO Capital”
全部
7,758
临床试验
2,750
药物
1,182
机构
306
资讯
3,520
去年
IGM Biosciences Downgraded by BMO Capital Following Strategic Update
去年
Exelixis Downgraded to Market Perform Despite Price Target Increase to $40
去年
Intellia Therapeutics Announces Strategic Reorganization and 2025 Milestones
去年
AbbVie's Emraclidine Fails in Schizophrenia Trials, Analysts Still Bullish on Immunology Portfolio
去年
Subcutaneous Keytruda Meets Primary Endpoint in Phase III NSCLC Trial
2年前
BridgeBio Refocuses on Late-Stage Assets, Trims Pipeline to Sharpen Commercial Focus
去年
BridgeBio's Acoramidis Poised to Challenge Pfizer's Tafamidis in ATTR-CM Market
9个月前
FDA Official's Skepticism Triggers Disc Medicine Stock Decline Amid Bitopertin Review
去年
Intellia Therapeutics' NTLA-2002 Shows Promise in Phase II Trials for Hereditary Angioedema
去年
Biogen Executives Address Investor Pressure and Strategic Focus at JPM25
第 1 页,共 352 页
上一页
下一页